| Acute coronary syndrome | 137 |
| Acute decompensated heart failure | 83 |
| Acute kidney injury | 83 |
| Acute myocardial infarction | 72, 175 |
| Admission blood glucose | 137 |
| Ambulatory blood pressure variability | 32 |
| Aortic valvular stenosis | 144 |
| Aortopulmonary window | 144 |
| Apparent diffusion coefficient | 57 |
| Ascending aortic aneurysm | 160 |
| Atherogenic index of plasma | 32 |
| Atrial fibrillation | 167 |
| Blood pressure | 191 |
| Calf deep vein thrombosis | 57 |
| Cardio-renal syndrome type 1 | 83 |
| Cardiovascular risk perception | 93 |
| CHA2DS2-VASc score | 167 |
| Children | 100 |
| Coronary artery disease | 32, 167 |
| Coronary tortuosity | 167 |
| COVID-19 | 184 |
| COVID-19 pneumonia | 148 |
| Cryptogenic stroke | 47 |
| Cystatin C | 83 |
| DAPT score | 175 |
| De Simone’s formula | 18 |
| Diabetes | 130 |
| Diabetes mellitus | 72 |
| Dietary habits | 93 |
| Diffusion-weighted imaging | 57 |
| Doppler ultrasound | 57 |
| Education levels | 93 |
| Electrophysiology | 114 |
| EMR | 137 |
| Endothelial dysfunction | 130 |
| Endovascular treatment | 123 |
| Eosinophil/monocyte ratio | 137 |
| Epilepsy | 25 |
| Exercise stress test | 64, 191 |
| Exercise treadmill testing | 184 |
| Extended-release | 40 |
| Flap | 110 |
| Flow-mediated dilation | 130 |
| Fractional flow reserve | 18 |
| Gracilis | 110 |
| Heart rate | 191 |
| Heart rate recovery | 191 |
| Heart transplant | 148 |
| Hyperglycemia | 72, 130 |
| Iliac artery occlusion | 123 |
| Immunosuppression | 148 |
| In-stent restenosis | 12 |
| Infection | 110 |
| Instent restenosis | 137 |
| Insulin resistance | 12 |
| Ischemic modified albumin | 64 |
| Kissing balloon technique | 123 |
| Left ventricular mass | 100 |
| Left ventricular metabolic index | 4 |
| Lifestyles | 93 |
| Management | 40 |
| Masks | 184 |
| Mildly reduced ejection fraction | 4 |
| Mortality | 25, 72 |
| MRI | 57 |
| Neutrophil/lymphocyte ratio | 160 |
| Non-ST-segment myocardial infarction | 72 |
| NT-proBNP | 4 |
| Obesity | 100 |
| Open heart surgery | 25 |
| Pacemakers | 114 |
| Patent foramen ovale | 47 |
| Percutaneous closure of patent foramen ovale | 47 |
| Percutaneous coronary intervention | 175 |
| Post-COVID-19 | 191 |
| Prosthetic graft | 110 |
| Prosthetic heart valve | 153 |
| Prosthetic heart valve dysfunctions | 153 |
| Pulmonary hypertension | 144 |
| Registries | 114 |
| Seizures | 25 |
| Sport | 184 |
| Sports | 100 |
| Stable angina pectoris | 64 |
| Stuck and restricted leaflet | 153 |
| Supravalvular aortic stenosis | 144 |
| Systemic immune inflammatory index | 160 |
| Thrombus burden | 175 |
| Triglyceride glucose index | 12 |
| Uric acid | 160 |
| Vascular | 110 |
| Verapamil intoxication | 40 |
| Whole blood viscosity | 18 |